PFC
MYGN icon

Phocas Financial Corp’s Myriad Genetics MYGN Stock Holding History

Phocas Financial Corp’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-130,705
Closed -$2.49M – 330
2022
Q3 		$2.49M Buy
130,705
+2,756
+2% +$63.2K 0.39% 106
2022
Q2 		$2.33M Sell
127,949
-1,486
-1% -$30.9K 0.35% 111
2022
Q1 		$3.26M Sell
129,435
-2,666
-2% -$68.2K 0.41% 103
2021
Q4 		$3.65M Sell
132,101
-3,166
-2% -$91.7K 0.46% 89
2021
Q3 		$4.37M Buy
135,267
+27,568
+26% +$915K 0.55% 78
2021
Q2 		$3.29M Buy
+107,699
New +$3.11M 0.41% 101
2019
Q1 		– Sell
-120
Closed -$3K – 261
2018
Q4 		$3K Buy
+120
New +$4.32K ﹤0.01% 320

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Phocas Financial Corp's MYGN Position: Q4 2022 in Review

Phocas Financial Corp sold out of Myriad Genetics (MYGN) in Q4 2022, closing a stake of 130,705 shares — an estimated $2.49M sold.

Phocas Financial Corp first reported a position in MYGN in Q4 2018 and held it in 7 quarters. The position peaked at $4.37M in Q3 2021. 197 funds tracked by Wall St. Rank hold MYGN as of Q4 2022.

  • Phocas Financial Corp reported no remaining Myriad Genetics position as of Q4 2022 after selling out during the quarter.
  • Phocas Financial Corp sold 130,705 Myriad Genetics shares in Q4 2022, an estimated $2.49M.
  • Phocas Financial Corp first reported a position in Myriad Genetics in Q4 2018 and held it in 7 quarters.
  • Phocas Financial Corp's Myriad Genetics position peaked at $4.37M in Q3 2021.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2022.

Based on Phocas Financial Corp's 13F filing for Q4 2022, filed 11 Jan 2023.